Regulation of trophoblast cell invasion by Pyruvate Kinase isozyme M2 (PKM2)

Kary Y F Tsai1, Benton Tullis1, Juan Mejia1

  • 1Lung and Placenta Research Laboratory, Brigham Young University, Department of Physiology and Developmental Biology, Provo, UT, USA.

Placenta
|October 18, 2020
PubMed

Insights

Pyruvate kinase M2 (PKM2) regulates trophoblast invasion, impacting placental development in intrauterine growth restriction (IUGR). Activating PKM2 may reverse IUGR-related weight loss, suggesting its therapeutic potential.

Area of Science:

  • Cell Biology
  • Metabolic Regulation
  • Reproductive Medicine

Background:

  • Pyruvate kinase isozymes M2 (PKM2) is a key glycolytic enzyme found in proliferating cells, including the placenta.
  • Upregulated placental PKM2 has been observed in human intrauterine growth restriction (IUGR).

Purpose of the Study:

  • To investigate PKM2's role in trophoblast invasion and localization.
  • To examine PKM2's regulation by mTOR signaling.
  • To assess the therapeutic potential of PKM2 activation in IUGR models.

Main Methods:

  • Immunohistochemistry and Western blot analysis of human placental tissues.
  • In vitro culture of trophoblast cells under normoxic and hypoxic conditions.
  • Assessment of cell invasion, PKM2 expression, and mTOR activity.
  • In vivo studies evaluating PKM2 activation effects on placental and fetal weights.

Main Results:

  • Elevated phosphorylated PKM2 (p-PKM2) levels in IUGR samples.
  • Differential trophoblast PKM2 localization and expression under varying oxygen conditions.
  • mTOR inhibition decreased trophoblast invasion and PKM2 expression.
  • PKM2 activation protected against reduced placental and fetal weights in vivo.

Conclusions:

  • PKM2 regulates trophoblast invasion, influenced by its subcellular localization and cellular oxygen levels.
  • mTOR signaling modulates trophoblast PKM2 expression and activity.
  • PKM2 activation demonstrates potential to counteract IUGR-associated growth deficits, highlighting its role in complicated pregnancies.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.1K